TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23795326

Group type: EXPERIMENTAL
Intervention: Preoperative patient education (oral and written)
Number of subjects: 135

Group type: COMPARATOR
Intervention: No preoperative patient education (control group)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Preoperative patient education
Number of subjects: 135
Study: 21225239

Group type: EXPERIMENTAL
Intervention: Candesartan, 32 mg once daily
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 18996032

Group type: EXPERIMENTAL
Intervention: Arthrocentesis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 15
Study: 17943080

Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 339

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 339
Study: 15114554

Group type: EXPERIMENTAL
Intervention: Parents of asthmatic children
Number of subjects: 863

Group type: COMPARATOR
Intervention: Health professionals (specialists)
Number of subjects: 863

Group type: COMPARATOR
Intervention: Local clinicians
Number of subjects: 863

Group type: COMPARATOR
Intervention: Parents (general)
Number of subjects: 863
Study: 11817925

Group type: EXPERIMENTAL
Intervention: Social influences, self-efficacy, perceived benefits, and perceived barriers
Number of subjects: 2390

Group type: EXPERIMENTAL
Intervention: Competition as a perceived benefit
Number of subjects: 2390

Group type: EXPERIMENTAL
Intervention: Health as a perceived benefit
Number of subjects: 2390

Group type: EXPERIMENTAL
Intervention: Health concerns as perceived barriers
Number of subjects: 2390
Study: 9849107

Group type: EXPERIMENTAL
Intervention: Partial report trials
Number of subjects: 26

Group type: COMPARATOR
Intervention: Whole report trials
Number of subjects: 26
Study: 8190433

Group type: EXPERIMENTAL
Intervention: Trial of labor
Number of subjects: 7229

Group type: COMPARATOR
Intervention: Elective repeat cesarean
Number of subjects: 7229
Study: 2678885

Group type: EXPERIMENTAL
Intervention: Savlon as a cleansing agent before ocular surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Betadine as a safer antiseptic
Number of subjects: 0
Study: 4855182

Group type: EXPERIMENTAL
Intervention: Therapists' affective responses to patients or families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment prognosis ratings by therapists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ratings of psychopathology
Number of subjects: 0
Study: 31078139

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 94
Study: 27811168

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 220

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 220
Study: 25858909

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 µg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 µg twice daily (excluding patients who changed prednisolone dose)
Number of subjects: 30
Study: 22841906

Group type: EXPERIMENTAL
Intervention: Temporary biventricular pacing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care (no pacing)
Number of subjects: 50
Study: 21145862

Group type: EXPERIMENTAL
Intervention: Enhanced counseling (intervention group)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Standard counseling (attention-control group)
Number of subjects: 355
Study: 19695749

Group type: EXPERIMENTAL
Intervention: Surgical knee
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-involved limb
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control limbs
Number of subjects: 18
Study: 17258770

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 1484

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1484
Study: 15065933

Group type: EXPERIMENTAL
Intervention: Lag-2 structure learning in young participants
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lag-2 structure learning in older participants
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lag-3 structure learning in young participants
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lag-3 structure learning in older participants
Number of subjects: 48
Study: 11211366

Group type: COMPARATOR
Intervention: Methylphenidate (MPH) - doses: placebo, low, middle, high
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - total daily dose limit of 35 mg for children weighing less than 25 kg
Number of subjects: 289
Study: 9644316

Group type: EXPERIMENTAL
Intervention: Weekly chemotherapy (Arm B): CDDP (40 mg/m2), VDS (3 mg/m2), MMC (4 mg/m2) on day 1, followed by CDDP (20 mg/m2), VDS (1.5 mg/m2), MMC (2 mg/m2) weekly.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Monthly chemotherapy (Arm A): CDDP (80 mg/m2) monthly on day 1, VDS (3 mg/m2) on days 1 and 8, MMC (8 mg/m2) on day 1.
Number of subjects: 78
Study: 7829187

Group type: EXPERIMENTAL
Intervention: Group II - opposite hip flexed beyond 90 degrees, abducted and externally rotated
Number of subjects: 100

Group type: COMPARATOR
Intervention: Group I - opposite hip brought to full abduction, neutral flexion and neutral rotation
Number of subjects: 100
Study: 2513239

Group type: EXPERIMENTAL
Intervention: Same-day sigmoidoscopy and double contrast barium enema
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Same-day sigmoidoscopy
Number of subjects: 400
Study: 50948

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Organic torticollis patients
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Psychogenic torticollis patients
Number of subjects: 8
Study: 31564829

Group type: EXPERIMENTAL
Intervention: New generic formulation of S-1
Number of subjects: 29

Group type: COMPARATOR
Intervention: Branded reference formulation of S-1
Number of subjects: 29
Study: 28158239

Group type: EXPERIMENTAL
Intervention: Fruit and Vegetable Intervention (FVI)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Diet-as-usual control
Number of subjects: 171

Group type: COMPARATOR
Intervention: Ecological Momentary Intervention (EMI)
Number of subjects: 171
Study: 24955942

Group type: EXPERIMENTAL
Intervention: Healthy eating guidance and monitoring by parents
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Lack of parental control (child control)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Parents of fussy eaters
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Fussy eaters
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Fussy eaters with food-restrictive parents
Number of subjects: 203
Study: 22925226

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) at a maximum dose of 3000 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 16945231

Group type: EXPERIMENTAL
Intervention: Diazepam administered
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Midazolam administered
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo with saline administration
Number of subjects: 252
Study: 12656544

Group type: EXPERIMENTAL
Intervention: Postoperative urine output
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Serum creatinine levels
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Measured creatinine clearance (CrCl)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Schwartz equation for estimating CrCl
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Correlation between measured CrCl and serum creatinine or urine production
Number of subjects: 14
Study: 10356916

Group type: EXPERIMENTAL
Intervention: Metabolic complex of amino acids (100 mg 3 times a day for 20 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 90
Study: 8568118

Group type: EXPERIMENTAL
Intervention: Acetate alone (56.25 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetate plus propionate (56.25 mmol/L + 18.75 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetate plus calcium (56.25 mmol/L + 50 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetate, propionate, and calcium together (56.25 mmol/L + 18.75 mmol/L + 50 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propionate alone (18.75 mmol/L)
Number of subjects: 6
Study: 1836088

Group type: EXPERIMENTAL
Intervention: lynestrenol 5-10 mg
Number of subjects: 87

Group type: COMPARATOR
Intervention: DMPA (intramuscular administration)
Number of subjects: 87
Study: 7058319

Group type: EXPERIMENTAL
Intervention: bezafibrate (3 X 200 mg daily)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: colestipol (2 X 10 g per day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: probucol (2 X 500 mg daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: dietary treatment alone
Number of subjects: 66

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study: 31412278

Group type: EXPERIMENTAL
Intervention: Stress group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 27276431

Group type: EXPERIMENTAL
Intervention: Formula containing 25 mg ARA/100 kcal
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Formula containing 34 mg ARA/100 kcal
Number of subjects: 89

Group type: COMPARATOR
Intervention: Formula containing 0 mg ARA/100 kcal
Number of subjects: 89
Study: 26691663

Group type: EXPERIMENTAL
Intervention: Web-based mindfulness training course
Number of subjects: 30
Study: 23765601

Group type: EXPERIMENTAL
Intervention: Ulinastatin (ulinastatin group - UG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 21517195

Group type: EXPERIMENTAL
Intervention: Low-magnitude voucher condition
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-magnitude voucher condition
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall treatment response
Number of subjects: 36

Group type: COMPARATOR
Intervention: Interaction between DD and treatment condition
Number of subjects: 36
Study: 18359421

Group type: EXPERIMENTAL
Intervention: High pretest probability
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Moderate pretest probability
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Low pretest probability
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Modified CPIS
Number of subjects: 740
Study: 16867025

Group type: EXPERIMENTAL
Intervention: Zolpidem modified-release (MR) 12.5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zolpidem immediate-release (IR) 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zolpidem intravenous (i.v.) infusion 8 mg
Number of subjects: 24
Study: 14564336

Group type: EXPERIMENTAL
Intervention: Freestyle valve
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mosaic valve
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ultracor valve
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ATS valve
Number of subjects: 39
Study: 10847261

Group type: EXPERIMENTAL
Intervention: CQP materials
Number of subjects: 3627

Group type: EXPERIMENTAL
Intervention: CQP materials and outbound telephone call
Number of subjects: 3627

Group type: COMPARATOR
Intervention: User's guide and audiotape (UG group)
Number of subjects: 3627
Study: 9015779

Group type: EXPERIMENTAL
Intervention: Grass pollen extract (active product)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1354275

Group type: EXPERIMENTAL
Intervention: Fluorouracil (1 g per day) plus heparin (10,000 U per day) during and after surgery for 7 days
Number of subjects: 398

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 398

Group type: COMPARATOR
Intervention: Surgery-only
Number of subjects: 398
Study: 6352304

Group type: EXPERIMENTAL
Intervention: Inhaled beta-2-agonists (2.5 mg terbutaline)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intramuscular dosed beta-2-agonists (1/4 mg terbutaline)
Number of subjects: 10
Study: 30650256

Group type: EXPERIMENTAL
Intervention: Topical GSK1940029 (0.3% and 1%, occluded application)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Topical GSK1940029 (0.1% to 1%, single and repeat doses, occluded and nonoccluded applications)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Topical GSK1940029 (0.1% to 1%, occluded application)
Number of subjects: 93
Study: 28818853

Group type: EXPERIMENTAL
Intervention: Immediate cord clamping
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed cord clamping
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SVC flow measurements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RVO measurements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DA diameter measurements
Number of subjects: 40
Study: 26812304

Group type: EXPERIMENTAL
Intervention: Stress urinary incontinence
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Partners of females with stress urinary incontinence
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Couples with stress urinary incontinence
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Females with stress urinary incontinence
Number of subjects: 134
Study: 24074649

Group type: EXPERIMENTAL
Intervention: Intensive MI (9 sessions)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Standard MI (1 session)
Number of subjects: 163
Study: 22391083

Group type: EXPERIMENTAL
Intervention: Sphenopalatine artery ligation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endoscopic inferior turbinoplasty without sphenopalatine artery ligation
Number of subjects: 30
Study: 20628884

Group type: EXPERIMENTAL
Intervention: Diet-Exercise (DE) group
Number of subjects: 19

Group type: COMPARATOR
Intervention: Diet (D) group
Number of subjects: 19
Study: 17222278

Group type: EXPERIMENTAL
Intervention: Brief personalized assessment-feedback on male and female population drinking norms by mail
Number of subjects: 1727

Group type: COMPARATOR
Intervention: Delayed-treatment control group
Number of subjects: 1727
Study: 15822121

Group type: EXPERIMENTAL
Intervention: Pap interval of 8-30 days
Number of subjects: 5055

Group type: EXPERIMENTAL
Intervention: Pap interval of 121-184 days
Number of subjects: 5055

Group type: COMPARATOR
Intervention: CIN3 group
Number of subjects: 5055
Study: 12062912

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 10218659

Group type: EXPERIMENTAL
Intervention: Reformulated Ensure (Re‐En)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard Ensure (En)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both Re‐En and En
Number of subjects: 32
Study: 8829954

Group type: EXPERIMENTAL
Intervention: Lipid-lowering drugs and diet (2 to 3 years)
Number of subjects: 1240

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle changes (stress management, intensive exercise, low fat diet) (1 to 3 years)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1240
Study: 2090478

Group type: EXPERIMENTAL
Intervention: Theophylline with manufacturer's insert (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Theophylline without manufacturer's insert (Group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Theophylline (both groups)
Number of subjects: 40
Study: 346140

Group type: EXPERIMENTAL
Intervention: Bulk forming agent (ispaghula husk)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 30543570

Group type: EXPERIMENTAL
Intervention: Home-based nursing interventions informed by the Health Belief Model
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 61
Study: 31345179

Group type: EXPERIMENTAL
Intervention: APAD intervention (thrice-weekly moderate-intensity mixed aerobic and resistance exercise sessions and 9 dietetic consultations)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: APAD intervention
Number of subjects: 143

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 143
Study: 29059644

Group type: EXPERIMENTAL
Intervention: Resveratrol at a dose of 100 mg per os daily added to standard therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard therapy (Β‐blockers, statins, aspirin)
Number of subjects: 85
Study: 25231029

Group type: COMPARATOR
Intervention: SLA implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: SLActive implants
Number of subjects: 20
Study: 24325653

Group type: EXPERIMENTAL
Intervention: Doktor Muda Programme (DMP)
Number of subjects: 3455

Group type: COMPARATOR
Intervention: Non-DMP (control)
Number of subjects: 3455
Study: 21840840

Group type: EXPERIMENTAL
Intervention: TCARE® intervention
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study: 19892299

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCH 53048
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terutroban (S18886)
Number of subjects: 0
Study: 16399214

Group type: EXPERIMENTAL
Intervention: Growth hormone releasing hormone (GHRH)
Number of subjects: 89
Study: 15513305

Group type: EXPERIMENTAL
Intervention: Amlodipine-based antihypertensive therapy
Number of subjects: 42
Study: 11757505

Group type: EXPERIMENTAL
Intervention: Folate treatment (1 mg folic acid, 400 microg vitamin B12, 10 mg pyridoxine)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Folate treatment
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 9056055

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8373297

Group type: EXPERIMENTAL
Intervention: Platinum-modified amalgam
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Palladium-modified amalgam
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Dispersed phase amalgam
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: All three alloys
Number of subjects: 59

Group type: COMPARATOR
Intervention: Static creep
Number of subjects: 59
Study: 3003206

Group type: EXPERIMENTAL
Intervention: Acyclovir (10 mg/kg) administered intravenously at 8-hr intervals for seven days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Acyclovir (10 mg/kg)
Number of subjects: 31
Study: 31330457

Group type: EXPERIMENTAL
Intervention: Multiple-injection paravertebral block (PVB)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Single-injection erector spinae plane block (ESPB)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intercostal nerve block (ICNB)
Number of subjects: 72
Study: 29291958

Group type: EXPERIMENTAL
Intervention: SPF 100+ sunscreen
Number of subjects: 199

Group type: COMPARATOR
Intervention: SPF 50+ sunscreen
Number of subjects: 199
Study: 26882453

Group type: EXPERIMENTAL
Intervention: Docetaxel (TXT) + Tamoxifen (TAM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Docetaxel (TXT)
Number of subjects: 120
Study: 23563752

Group type: EXPERIMENTAL
Intervention: Olmesartan (n = 70)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control group (n = 65)
Number of subjects: 247
Study: 22402710

Group type: EXPERIMENTAL
Intervention: Above-ankle orthosis (AABA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Below-ankle orthosis (BA)
Number of subjects: 0
Study: 21077581

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 18996235

Group type: EXPERIMENTAL
Intervention: Pushrim-activated power-assisted wheelchairs (PAPAWs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Manual wheelchair propulsion
Number of subjects: 18
Study: 15966878

Group type: EXPERIMENTAL
Intervention: Ultrasonic root debridement on the second molar followed by a three‐visit plaque control programme
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard socket debridement
Number of subjects: 30
Study: 12069217

Group type: EXPERIMENTAL
Intervention: Parental monitoring intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control dyads
Number of subjects: 0
Study: 10073741

Group type: EXPERIMENTAL
Intervention: xamoterol (2 x 200 mg day(‐1) p.o.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: xamoterol (2 x 200 mg day(‐1) p.o.) after 2 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: ketotifen (2 x 1 mg day(‐1) p.o.)
Number of subjects: 10
Study: 7668851

Group type: EXPERIMENTAL
Intervention: Bone Up On Arthritis (BUOA) intervention delivered by community-based service organization
Number of subjects: 154
Study: 2209920

Group type: EXPERIMENTAL
Intervention: Topical flurbiprofen
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Prednisolone 0.3%
Number of subjects: 77
Study: 7030976

Group type: EXPERIMENTAL
Intervention: Proxyphylline (500 mg orally three times daily) + Salbutamol (3 mg p.o.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proxyphylline (500 mg orally three times daily) + Placebo
Number of subjects: 0
Study: 6387888

Group type: EXPERIMENTAL
Intervention: Metoprolol (50-100 mg twice daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31994510

Group type: EXPERIMENTAL
Intervention: Migrepam (zolmitriptan) 2.5 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sumatriptan 50 mg
Number of subjects: 60
Study: 29927666

Group type: EXPERIMENTAL
Intervention: BikeSafe on-bicycle curriculum (intervention group)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 286
Study: 26785820

Group type: EXPERIMENTAL
Intervention: Quercetin (500 mg daily for 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 25391155

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 22682883

Group type: EXPERIMENTAL
Intervention: Nasogastric (NG) feeding route
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nasoduodenal (ND) feeding route
Number of subjects: 101
Study: 20605484

Group type: EXPERIMENTAL
Intervention: Autologous platelet gel (APG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (standard surgical treatment without APG)
Number of subjects: 35